Page last updated: 2024-09-04

gadolinium dtpa and Albuminuria

gadolinium dtpa has been researched along with Albuminuria in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bardak, S; Gok Oguz, E; Horoz, M; Kiykim, A; Muslu, N; Olmaz, R; Ozhan, O; Sungur, MA; Turgutalp, K	1
Adams, DF; Boyce, RW; Jucker, BM; Lenhard, SC; Mirabile, RC; Nerurkar, SS; Schaeffer, TR; Willette, RN	1

Trials

1 trial(s) available for gadolinium dtpa and Albuminuria

Article	Year
Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injury. Medical science monitor : international medical journal of experimental and clinical research, 2013, Nov-06, Volume: 19 Topics: Acetylglucosaminidase; Acute Kidney Injury; Aged; Aged, 80 and over; Albuminuria; Case-Control Studies; Contrast Media; Creatinine; Cystatin C; Female; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney; Magnetic Resonance Imaging; Male; Prospective Studies	2013

Article

Year

Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injury.

Medical science monitor : international medical journal of experimental and clinical research, 2013, Nov-06, Volume: 19

Topics: Acetylglucosaminidase; Acute Kidney Injury; Aged; Aged, 80 and over; Albuminuria; Case-Control Studies; Contrast Media; Creatinine; Cystatin C; Female; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney; Magnetic Resonance Imaging; Male; Prospective Studies

2013

Other Studies

1 other study(ies) available for gadolinium dtpa and Albuminuria

Article	Year
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:3 Topics: Albuminuria; Animals; Contrast Media; Creatinine; Dietary Fats; Endothelium, Vascular; Enzyme Inhibitors; Gadolinium DTPA; Glomerular Filtration Rate; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Kidney Function Tests; Magnetic Resonance Imaging; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Inbred SHR; Sodium, Dietary; Stroke	2003

Article

Year

p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.

The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:3

Topics: Albuminuria; Animals; Contrast Media; Creatinine; Dietary Fats; Endothelium, Vascular; Enzyme Inhibitors; Gadolinium DTPA; Glomerular Filtration Rate; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Kidney Function Tests; Magnetic Resonance Imaging; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Inbred SHR; Sodium, Dietary; Stroke

2003